Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 27Endocrine 1Breast 1

Conditions

Multiple Endocrine Neoplasia Type 1 96Pituitary Neoplasms 56Neuroendocrine Tumors 50Thyroid Cancer, Papillary 42Thyroid Neoplasms 16Obesity 15Pheochromocytoma 14Overweight 11Adrenal Gland Neoplasms 10Weight Loss 9Paraganglioma 9Carcinoma, Neuroendocrine 9Pancreatic Neoplasms 8Prostatic Neoplasms 7Motor Activity 7Insulinoma 7Gastrointestinal Neoplasms 7Brain Neoplasms 7Adrenocortical Adenoma 7Acquired Immunodeficiency Syndrome 7Neoplasm Metastasis 6Hyperaldosteronism 6Carcinoma, Medullary 6Stomach Neoplasms 5Osteoporosis 5Neoplasms 5Meningioma 5Liver Neoplasms 5Insulin Resistance 5HIV Infections 5

Interventions

Microspheres 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Prostatic Hyperplasia × Endocrine × Clear all
NCT02167919 2017-09-14

Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)

University of North Carolina, Chapel Hill

Phase NA Completed
15 enrolled
EndocrineGenitourinary

Hyperplasia, Prostatic Hyperplasia, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡